Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
GEN1047 is a bispecific antibody that induces T-cell mediated cytotoxicity of B7H4-positive tumor cells · 1 trial · 4 indications
| Name | Type | Description |
|---|---|---|
| GEN1047 is a bispecific antibody that induces T-cell mediated cytotoxicity of B7H4-positive tumor cells. | BIOLOGICAL | GEN1047 will be administered as an intravenous infusion. The dose-levels will be determined by the starting dose and the escalation steps taken in the trial. |